n-coder scfv (BioInvent)
90
Structured Review
BioInvent
n-coder scfv
N Coder Scfv, supplied by BioInvent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n-coder+scfv/n+coder++scfv+library/pmc07526549-137-3-3
Average 90 stars, based on 1 article reviews
N Coder Scfv, supplied by BioInvent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n-coder+scfv/n+coder++scfv+library/pmc07526549-137-3-3
Average 90 stars, based on 1 article reviews
n-coder scfv - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation"
Article Title: LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
Journal: JCI Insight
doi: 10.1172/jci.insight.141593
Figure Legend Snippet: ( A ) Schematic of antibody generation by phage-display via 3 independent “panning” techniques; (i) immobilized target (LILRB3), (ii) biotinylated target and excess nontarget (LILRB1), and (iii) LILRB3-transfected cell lines (from left to right). Biopanning was performed against generated target protein using an scFv library; “nontarget” cross-reactive scFv clones were removed by competition, and target-specific scFv clones were then eluted and converted to a soluble format, sequenced, and screened by various cell- and protein-based assays. ( B and C ) Screening of generated LILRB3 clones. ( B ) FMAT and ( C ) ELISA were performed and scFv clones screened against LILRB3 target– and LILRB1/LILRB2 nontarget–transfected CHO-S cells and extracellular LILRB1 protein, respectively. The relative binding to each target was calculated, with target-specific scFv clones depicted in yellow and the irrelevant isotype control shown in green. Nonbinding and cross-reactive scFv clones depicted in blue. ( D ) Screening of LILRB3 scFv clones by high-throughput flow cytometry. PBMCs (left plot) or LILR-transfected CHO-S (middle plot) cells were incubated with His-tagged scFv supernatants, followed by secondary anti-His staining. Where transfected CHO-S cells were used, LILRB1- and LILRB2-transfected cells were used as nontargets for LILRB3. Clones were compared against both gated CD14 + monocytes and target-transfected CHO-S cells (right plot). LILRB3-specific clones highlighted in yellow, nonspecific or nonbinding clones in red, and isotype control in green. ( E ) Specificity of LILRB3 clones against human LILR-transfected 2B4 cells. LILRB3 mAbs were tested against cells stably transfected with the indicated LILR family members by flow cytometry; a representative specific clone (A16; top panel) and a nonspecific cross-reactive clone (A30; bottom panel) are shown. ( F – G ) Testing the specificity of directly fluorochrome-labeled LILRB3 clones against primary cells by flow cytometry. ( F ) Fresh whole peripheral blood stained with either APC-labeled LILRB3 (represented by clone A16) or an irrelevant human (h) IgG1 isotype control as well as various leukocyte surface markers, as indicated. Dot plots and histograms are representative of multiple donors indicating gating of each leukocyte subset as indicated: T cells, B cells, NK cells, monocytes, and granulocytes. ( G ) Graph showing relative expression of LILRB3 on each leukocyte subset. One-way ANOVA test performed (* P < 0.05; ** P < 0.005); n = 5 independent donors (each color represents an individual donor). ( E – F ) Histogram pink and blue traces indicate staining with irrelevant isotype control or LILRB3 mAb, respectively.
Techniques Used: Transfection, Generated, Clone Assay, Enzyme-linked Immunosorbent Assay, Binding Assay, Control, High Throughput Screening Assay, Flow Cytometry, Incubation, Staining, Stable Transfection, Labeling, Expressing
Related Articles
other:Article Title: Method of generating a synthetic antibody library, said library and application(s) thereof Article Snippet: The same frame work was used by Article Title: Antibodies and nucleotide sequences, and uses thereof Article Snippet: Isolation of scFv Antibody Fragments The Article Title: Modulators Article Snippet: IM-9 cells were obtained from the American Type Culture Collection (ATCC) and maintained in RPMI 1640+10% FBS. Article Title: A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia Article Snippet: Cell lines (Raji: Burkitt’s Lymphoma, RPMI 8226: multiple myeloma, DU 145: prostate cancer, LoVo: colorectal adenocarcinoma, MCF7: breast adenocarcinoma and HS-5: immortalized bone marrow stromal cells) used in the binding pattern analysis were obtained from ATCC and cultured according to the suppliers’ instructions. Article Title: Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens Article Snippet: Labeled target cells (10, 2.5, 5, or 5 million cells in selections 1, 2, 3, and 4, respectively) were mixed with approximately 1000 times excess of Jurkat nontarget cells and incubated with the Article Title: LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation Article Snippet: In panning 1, Article Title: Agonistic anti TNFR2 antibody molecules Article Snippet: Isolation of scFv Antibody Fragments The Gentle:Article Title: Modulators Article Snippet: .. For the first round of phage panning, 1.6×1011 cfu of phage particles from an |